https://www.selleckchem.com/pr....oducts/MGCD0103(Moce
2%). Age ≥ 65 years, CK ≥ 180 U/L, and CD4+ T-cell counts 300 cells/µL at admission were risk factors independently associated with disease progression to severe COVID-19 during 14 days after admission and are therefore potential markers for disease progression in patients with milder COVID-19. Age ≥ 65 years, CK ≥ 180 U/L, and CD4+ T-cell counts less then 300 cells/µL at admission were risk factors independently associated with disease progression to severe COVID-19 during 14 days after admission and are therefore po
Curtir
Comentario
Compartilhar
